FindTrial
Sign In

Clinical study of liver cancer

A study of clinical profile of hepatocellular carcinoma in a tertiary care hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/02/049609
Enrollment
50
Registered
2023-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C220- Liver cell carcinoma

Interventions

None listed

Sponsors

Kasturba Medical College, Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed hepatocellular carcinoma cases and already diagnosed cases on follow up

Exclusion criteria

Exclusion criteria: Age less than 18 years

Design outcomes

Primary

MeasureTime frame
To study the clinical profile of Hepatocellular Carcinoma using history, examination, lab parameters and radiological investigations. Barcelona Clinic Liver Cancer Staging System (BCLC) will be used to assess the severity at presentation. Timepoint: Newly diagnosed Hepatocellular carcinoma patients and already diagnosed cases on follow up to Kasturba Hospital, Manipal during the period of study of 1 year and 6 months.—

Secondary

MeasureTime frame
Knowing the clinical profile of the patient and correlating it to the severity of hepatocellular carcinoma at presentation can help predict the course of the disease and thus help adopt appropriate treatment course to reduce the morbidity and mortality.Timepoint: Newly diagnosed Hepatocellular carcinoma patients and already diagnosed cases on follow up to Kasturba Hospital, Manipal during the period of study of 1 year and 6 months.—

Countries

India

Contacts

Public ContactShubha Seshadri

Kasturba Medical College, Manipal

shubhamanipal@yahoo.co.in9845563799

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026